Bronchiolitis: From Practice Guideline to Clinical Practice

Maybelle Kou; Vivian Hwang; Nadira Ramkellawan

doi:10.1016/j.emc.2017.12.006

Bronchiolitis: From Practice Guideline to Clinical Practice

Emerg Med Clin North Am. 2018 May;36(2):275-286. doi: 10.1016/j.emc.2017.12.006. Epub 2018 Feb 10.

Authors

Maybelle Kou¹, Vivian Hwang², Nadira Ramkellawan³

Affiliations

¹ The Altieri PEM Fellowship, Inova Fairfax Medical Campus, The George Washington University School of Medicine, Virginia Commonwealth University School of Medicine, Inova Fairfax Campus, 3300 Gallows Road, Falls Church, VA 22042, USA. Electronic address: maybelle.kou@inova.org.
² The Altieri PEM Fellowship, Inova Fairfax Medical Campus, The George Washington University School of Medicine, Virginia Commonwealth University School of Medicine, Inova Fairfax Campus, 3300 Gallows Road, Falls Church, VA 22042, USA.
³ Pediatric Emergency Medicine Fellow, The Altieri PEM Fellowship, Inova Fairfax Medical Campus, 3300 Gallows Road, Falls Church, VA 22042, USA.

PMID: 29622322
DOI: 10.1016/j.emc.2017.12.006

Abstract

The American Academy of Pediatrics' clinical practice guideline in bronchiolitis was last updated in 2014 with recommendations to improve care for pediatric patients with bronchiolitis. As most treatments of bronchiolitis are supportive, the guideline minimizes the breadth of treatments previously used and cautions the use of tests and therapies that have a limited evidence base. Emergency physicians must be familiar with the guidelines in order to apply best practices appropriately.

Keywords: AAP CPG; Bronchiolitis; Diagnosis; ED management; Guidelines pediatric respiratory emergency; RSV; Respiratory distress; Therapy.

Publication types

Review

MeSH terms

Bronchiolitis / diagnosis*
Bronchiolitis / therapy*
Bronchodilator Agents / therapeutic use
Child
Humans
Pediatric Emergency Medicine*
Practice Guidelines as Topic
Respiratory Insufficiency / diagnosis
Risk Assessment / methods
United States

Substances

Bronchodilator Agents